Skip to main content

Advertisement

Log in

Risk Factors for Central Compartment Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Meta-Analysis

  • Original Scientific Report
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

The surgical management of papillary thyroid microcarcinoma (PTMC), especially regarding the necessity of central lymph node dissection (CLND), remains controversial. This meta-analysis was conducted to investigate the clinicopathologic factors predictive of central compartment lymph node metastasis (CLNM) in patients diagnosed with PTMC.

Methods

PubMed, EMBASE, Ovid, Web of Science, and the Cochrane Library were searched from their inception to September 2013. Published studies that explored the association between clinicopathologic factors and CLNM in PTMC patients were included. From the identified studies, we extracted the number of individuals with or without each risk factor to calculate the CLNM-positive proportions and used fixed/random-effects models for the meta-analyses of overall relative risk (RR). The pooling analysis on the association between CLNM or the different CLNDs and prognosis was also conducted.

Results

A total of 19 eligible studies that included 8345 patients were identified. Three studies did therapeutic CLND, while the other 16 studies performed prophylactic CLND in PTMC patients. Meta-analyses revealed that CLNM was associated with male gender (RR = 1.36; 95 % CI 1.22–1.52, p = 0.001), younger age (<45 years; RR = 1.15; 95 % CI 1.04–1.27, p = 0.006), larger tumor size (>5 mm; RR = 1.51 95 % CI 1.32–1.65, p = 0.001), multifocality (RR = 1.40; 95 % CI 1.27–1.54, p = 0.001), and extrathyroidal extension (RR = 1.81; 95 % CI 1.34–2.43, p = 0.001). Meta-regression analysis indicated that a disparity in the proportion of PTMC patients with CLNM in each study was the main factor resulting in heterogeneity among the 19 studies. In addition, the pooling analyses suggested that CLNM did not significantly predict neck recurrences [hazard ratio (HR) = 0.95, 95 % CI 0.67–1.22, p = 0.054], and the prophylactic CLND group did not improve local control significantly compared to the therapeutic group (RR = 0.96, 95 % CI 0.46–2.01, p = 0.544).

Conclusion

Prophylactic CLND may be performed in PTMC patients with clinically uninvolved central lymph nodes but with high risk factors; multicenter studies with long-term follow-up are recommended to better understand the risk factors and surgical management for central nodes in PTMC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Abbreviations

DTC:

Differentiated thyroid cancer

PTC:

Papillary thyroid cancer

PTMC:

Papillary thyroid microcarcinoma

ETE:

Extrathyroidal extension

US:

Ultrasonography

FNA:

Fine-needle aspiration

CLNM:

Central lymph node metastasis

CLND:

Central lymph node dissection

ATA:

American Thyroid Association

AJCC:

American Joint Committee on Cancer

RR:

Relative risk

CI:

Confidence interval

References

  1. Hedinger C, Williams ED, Sobin LH (1989) The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 63(908–91):1

    Google Scholar 

  2. Chen AY, Jemal A, Ward EM (2009) Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 115:3801–3807

    Article  PubMed  Google Scholar 

  3. Grebe SK, Hay ID (1996) Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. Surg Oncol Clin N Am 5:43–63

    CAS  PubMed  Google Scholar 

  4. Ito Y, Uruno T, Nakano K et al (2003) An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13:381–387

    Article  PubMed  Google Scholar 

  5. Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214

    Article  PubMed  Google Scholar 

  6. Haugen BR, Alexander EK, Bible KC et al (2014) American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer ATA guidelines recommendations are taken from an ATA Satellite meeting in Chicago in June 2014, and may differ from the final published version

  7. Roh JL, Park JY, Park CI (2009) Prevention of postoperative hypocalcemia with routine oral calcium and vitamin D supplements in patients with differentiated papillary thyroid carcinoma undergoing total thyroidectomy plus central neck dissection. Cancer 115:251–258

    Article  CAS  PubMed  Google Scholar 

  8. Leboulleux S, Girard E, Rose M et al (2007) Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab 92:3590–3594

    Article  CAS  PubMed  Google Scholar 

  9. Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605

    Article  PubMed  Google Scholar 

  10. Zhou YL, Gao EL, Zhang W et al (2012) Factors predictive of papillary thyroid micro-carcinoma with bilateral involvement and central lymph node metastasis: a retrospective study. World J Surg Oncol 10:67

    Article  PubMed Central  PubMed  Google Scholar 

  11. Moon HJ, Kim EK, Yoon JH et al (2012) Clinical implication of elastography as a prognostic factor of papillary thyroid microcarcinoma. Ann Surg Oncol 19:2279–2287

    Article  PubMed  Google Scholar 

  12. Kim TY, Hong SJ, Kim JM et al (2008) Prognostic parameters for recurrence of papillary thyroid microcarcinoma. BMC Cancer 8:296

    Article  PubMed Central  PubMed  Google Scholar 

  13. Moon HJ, Kim EK, Chung WY et al (2011) Minimal extrathyroidal extension in patients with papillary thyroid microcarcinoma: is it a real prognostic factor? Ann Surg Oncol 18:1916–1923

    Article  PubMed  Google Scholar 

  14. So YK, Son YI, Hong SD et al (2010) Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections. Surgery 148:526–531

    Article  PubMed  Google Scholar 

  15. Zheng X, Wei S, Han Y et al (2013) Papillary microcarcinoma of the thyroid: clinical characteristics and BRAF(V600E) mutational status of 977 cases. Ann Surg Oncol 20:2266–2273

    Article  PubMed  Google Scholar 

  16. Zhao Q, Ming J, Liu C et al (2013) Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma. Ann Surg Oncol 20:746–752

    Article  PubMed  Google Scholar 

  17. Lee J, Park JH, Lee CR et al (2013) Long-Term Outcomes of Total Thyroidectomy Versus Thyroid Lobectomy for Papillary Thyroid Microcarcinoma: Comparative Analysis After Propensity Score Matching Thyroid

  18. Lee HS, Park HS, Kim SW et al (2013) Clinical characteristics of papillary thyroid microcarcinoma less than or equal to 5 mm on ultrasonography. Eur Arch Otorhinolaryngol 270:2969–2974

    Article  PubMed  Google Scholar 

  19. Kim KE, Kim EK, Yoon JH et al (2013) Preoperative prediction of central lymph node metastasis in thyroid papillary microcarcinoma using clinicopathologic and sonographic features. World J Surg 37:385–391. doi:10.1007/s00268-012-1826-3

    Article  PubMed  Google Scholar 

  20. Zhang L, Wei WJ, Ji QH et al (2012) Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients. J Clin Endocrinol Metab 97:1250–1257

    Article  CAS  PubMed  Google Scholar 

  21. Kim BY, Jung CH, Kim JW et al (2012) Impact of clinicopathologic factors on subclinical central lymph node metastasis in papillary thyroid microcarcinoma. Yonsei Med J 53:924–930

    Article  PubMed Central  PubMed  Google Scholar 

  22. Hyun SM, Song HY, Kim SY et al (2012) Impact of combined prophylactic unilateral central neck dissection and hemithyroidectomy in patients with papillary thyroid microcarcinoma. Ann Surg Oncol 19:591–596

    Article  PubMed  Google Scholar 

  23. Caliskan M, Park JH, Jeong JS et al (2012) Role of prophylactic ipsilateral central compartment lymph node dissection in papillary thyroid microcarcinoma. Endocr J 59:305–311

    Article  PubMed  Google Scholar 

  24. Lee KJ, Cho YJ, Kim SJ et al (2011) Analysis of the clinicopathologic features of papillary thyroid microcarcinoma based on 7-mm tumor size. World J Surg 35:318–323. doi:10.1007/s00268-010-0886-5

    Article  PubMed  Google Scholar 

  25. Ogilvie JB, Patel KN, Heller KS (2010) Impact of the 2009 American Thyroid Association guidelines on the choice of operation for well-differentiated thyroid microcarcinomas. Surgery 148:1222–1226 discussion 1226–1227

    Article  PubMed  Google Scholar 

  26. Lim YC, Choi EC, Yoon YH et al (2009) Central lymph node metastases in unilateral papillary thyroid microcarcinoma. Br J Surg 96:253–257

    Article  CAS  PubMed  Google Scholar 

  27. Lee SH, Lee SS, Jin SM et al (2008) Predictive factors for central compartment lymph node metastasis in thyroid papillary microcarcinoma. Laryngoscope 118:659–662

    Article  PubMed  Google Scholar 

  28. Wada N, Duh QY, Sugino K et al (2003) Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 237:399–407

    PubMed Central  PubMed  Google Scholar 

  29. Miccoli P, Minuto MN, Ugolini C et al (2007) Intrathyroidal differentiated thyroid carcinoma: tumor size-based surgical concepts. World J Surg 31:888–894

    Article  PubMed  Google Scholar 

  30. Lang BH, Lo CY, Chan WF et al (2007) Staging systems for papillary thyroid carcinoma: a review and comparison. Ann Surg 245:366–378

    Article  PubMed Central  PubMed  Google Scholar 

  31. Lee J, Park JH, Lee CR et al (2013) Long-term outcomes of total thyroidectomy versus thyroid lobectomy for papillary thyroid microcarcinoma: comparative analysis after propensity score matching. Thyroid 23:1408–1415

    Article  PubMed  Google Scholar 

  32. Mercante G, Frasoldati A, Pedroni C et al (2009) Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid 19:707–716

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This research was supported by Grants from the Key Project of Science and Technology Commission of Shanghai Municipality (11DJ1400200).

Conflict of interest

The authors have nothing to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Qing-hai Ji.

Additional information

Ning Qu and Ling Zhang contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qu, N., Zhang, L., Ji, Qh. et al. Risk Factors for Central Compartment Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Meta-Analysis. World J Surg 39, 2459–2470 (2015). https://doi.org/10.1007/s00268-015-3108-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-015-3108-3

Keywords

Navigation